Athersys Inc (ATHXQ)
OTCMKTS: ATHXQ · Delayed Price · USD
0.00
-0.0001 (-99.00%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Athersys Employees
Athersys had 24 employees as of December 31, 2022. The number of employees decreased by 80 or -76.92% compared to the previous year.
Employees
24
Change (1Y)
-80
Growth (1Y)
-76.92%
Revenue / Employee
$6,042
Profits / Employee
-$1,975,208
Market Cap
6.17K
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
ATHXQ News
- 9 months ago - Athersys Reports Third Quarter 2023 Financial Results and Business Highlights - Business Wire
- 10 months ago - Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives - Business Wire
- 10 months ago - Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios - Business Wire
- 10 months ago - Athersys Licenses its Animal Health Assets to Ardent Animal Health - Business Wire
- 10 months ago - Athersys Director Jane Wasman Appointed Board Chair - Business Wire
- 11 months ago - Grant Awarded to Newcastle University to Research Athersys' MultiStem® in Machine Perfusion Prior to Kidney Transplantation - Business Wire
- 1 year ago - Athersys, Inc. Announces Pricing of $3.5 Million Public Offering - Business Wire
- 1 year ago - Athersys Reports Second Quarter 2023 Financial Results and Business Highlights - Business Wire